CoChat

Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases

Open access
Geldenhuys, Werner J., Lin, Li, Darvesh, Altaf S., Sadana, Prabodh · 2017 · Drug Discovery Today
Cited by 64

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Although statins and other pharmacological approaches have improved the management of lipid abnormalities, there exists a need for newer treatment modalities especially for the management of hypertriglyceridemia. Lipoprotein lipase (LPL), by promoting hydrolytic cleavage of the triglyceride core of lipoproteins, is a crucial node in the management of plasma lipid levels. Although LPL expression and activity modulation is observed as a pleiotropic action of some the commonly used lipid lowering drugs, the deliberate development of drugs targeting LPL has not occurred yet. In this review, we present the biology of LPL, highlight the LPL modulation property of currently used drugs and review the novel emerging approaches to target LPL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2016.10.007

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 64

Metadata

Authors
Geldenhuys, W. J., Lin, L., Darvesh, A. S., & Sadana, P.
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2017-02
Volume
22
Issue
2
Pages
352-365
ISSN
1359-6446 (ISSN-L)
OpenAlex
W2534990463
Cited by
64
References
32
FWCI
4.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases. https://app.cochat.ai/papers/10.1016/j.drudis.2016.10.007
The paper
Geldenhuys, W. J., Lin, L., Darvesh, A. S., & Sadana, P. (2017). Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2016.10.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.